Global News

Report: Global clinical trial service market will reach $64B by 2020

Wednesday, February 8, 2017

Research and Markets research forecasts that the global clinical trial service market will likely reach more than $64 billion by 2020, up from $38.4 billion at present, representing a CAGR of 9% between 2015 and 2020. By 2020 the average clinical trial outsourcing penetration will likely reach around 72%. In other words, by then close to three fourths of clinical trials will likely be performed by professional CROs.

[Read More]

Quertle, Elsevier collaborate to integrate full-text searching with artificial intelligence discovery tool

Wednesday, February 8, 2017

Henderson, Nevada-based Quertle, developer of the first artificial intelligence (AI) biomedical big data discovery platform (BioAI) for biomedical literature, and Amsterdam-based Elsevier, a provider of scientific, technical and medical information products and services, announce that full-text searching of biomedical and life science content on ScienceDirect, Elsevier’s information source with over 14 million publications, will be integrated into Quertle’s artificial intelligence discovery product Qinsight.

[Read More]

Quotient Clinical acquires SeaView Research

Wednesday, February 8, 2017

Quotient Clinical, an early phase drug development services provider, has acquired SeaView Research, expanding its operations into the U.S. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early phase clinical experience of the combined business, enabling the company to deliver a broader set of services.

[Read More]

Study: Quality of randomized control trials not measuring up

Wednesday, February 8, 2017

A majority of healthcare studies are conducted using a randomized control trial (RCT). These trials randomly assign participants into groups who either receive or do not receive treatment. However, until the mid-1990s, some of these studies were falling victim to inadequate reporting, thereby causing confusing and potentially biased results. Reviewing the quality of RCTs in various surgical specialties by using standardized methods is becoming a common practice.

[Read More]

Chan Zuckerberg Biohub names first cohort of engineers, scientists and technologists

Wednesday, February 8, 2017

The Chan Zuckerberg Biohub (CZ Biohub) has announced its first cohort of 47 CZ Biohub Investigators from the faculty of the University of California, Berkeley, Stanford University and the University of California, San Francisco. This group includes both highly accomplished senior professors as well as up-and-coming young faculty. Each of the CZ Biohub Investigators will receive a five-year appointment and up to $1.5 million in funding to conduct life science research in their respective areas of expertise.

[Read More]

Aerie Pharmaceuticals appoints Huan Sheng director of Clinical Research and Drug Safety

Wednesday, February 8, 2017

Aerie Pharmaceuticals, a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, has announced the appointment of Huan Sheng, M.D., Ph.D., as director of Clinical Research and Drug Safety, reporting to Kristine Erickson, O.D., Ph.D., Aerie’s vice president of Clinical Research.

[Read More]

KCR celebrates 20th anniversary

Tuesday, February 7, 2017

In 2017, KCR celebrates its 20-year anniversary of contributing to the clinical R&D industry. The CRO was founded in 1997 by entrepreneur Marek Kiecana. Emerging from Central Europe, KCR today operates in 19 European countries as well as the U.S. and provides pharma and biotech companies with fully customized service solutions for optimized clinical trial execution.

[Read More]